Identification of patients at high risk for relapse by Merlin Assay (CP-GEP) in an independent cohort of patients with melanoma who did not undergo sentinel lymph node biopsy: head and neck subgroup analysis - T. Amaral; E. Chatziioannou; A. Nuebling; T. Sinnberg; H. Niessner; U. Leiter; J. Dwarkasing; T. Arentsen; C. Groß; A. Eggermont; L. Flatz; S. Forchhammer (EJC Skin Cancer)